BPC October 14 update

Regeneron REGN PDUFA 4/13/22; NRx NRXP +37% PM Data from ineligible subjects

Pre-Market Updates

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that the FDA accepted for priority review a Biologics License Application (BLA) for REGEN-COV to treat COVID-19, setting a target action date of April 13, 2022.

NRx Pharmaceuticals (NASDAQ: NRXP) announced the publication of peer-reviewed results of aviptadil to treat critical COVID-19 in those ineligible for participation in its Phase 2b/3 study. Shares are trading up 37% at $12.93 during the pre-market.

Altamira Therapeutics Ltd. (NASDAQ: CYTO) announced that its 510(k) application for pre-market clearance filed with the FDA for Bentrio nasal spray to treat airborne allergens cleared the Agency's acceptance review. Shares are trading up 7% at $1.70 during the pre-market.

Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) announced that it received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its application of REN001, which is currently being studied to treat mitochondrial myopathy and other rare genetic mitochondrial diseases. Shares are trading up 10% at $7.24 during the pre-market.

Pre-Market Advancers

CompanyPriceChange
VIRX
Viracta Therapeutics Inc.
$6.70+0.59  +9.66%
ATHA
Athira Pharma Inc.
$10.54+0.91  +9.45%
YMTX
Yumanity Therapeutics Inc.
$9.75+0.64  +7.03%
CBIO
Catalyst Biosciences Inc.
$3.69+0.17  +4.83%
DBTX
Decibel Therapeutics Inc.
$7.71+0.33  +4.47%
BSGM
BioSig Technologies Inc.
$2.59+0.11  +4.44%
MDNA
Medicenna Therapeutics Corp.
$2.64+0.11  +4.35%
IMNM
Immunome Inc.
$18.86+0.7225  +3.98%
SEEL
Seelos Therapeutics Inc.
$2.36+0.09  +3.96%
PALI
Palisade Bio Inc.
$2.91+0.11  +3.93%

Pre-Market Decliners

CompanyPriceChange
MTCR
Metacrine Inc.
$1.74-2.09  -54.57%
OCUL
Ocular Therapeutix Inc.
$7.84-2.99  -27.61%
AGEN
Agenus Inc.
$4.02-1.11  -21.64%
LVTX
LAVA Therapeutics N.V.
$6.21-0.94  -13.15%
SESN
Sesen Bio Inc.
$1.13-0.12  -9.60%
BFRA
Biofrontera AG
$5.10-0.405  -7.36%
PROG
Progenity Inc.
$2.33-0.17  -6.80%
HRMY
Harmony Biosciences Holdings Inc.
$38.04-2.71  -6.65%
ADMP
Adamis Pharmaceuticals Corporation
$1.08-0.07  -6.09%
BNTC
Benitec Biopharma Inc.
$3.50-0.22  -5.91%